Please click here to read the article about transcatheter aortic valve replacement (TAVR) devices manufactured by Boston Scientific based on extensive medical device research
About
Boston Scientific is a multinational medical device company specializing in the development, manufacture, and marketing of a range of medical devices and technologies for use in the diagnosis and treatment of various medical conditions. The company was founded in 1979 and has its headquarters in Marlborough, Massachusetts, USA. With operations in over 100 countries.
Boston Scientific offers a range of products including interventional cardiology devices, endoscopy devices, neurostimulation devices, and urology and gynecology devices. The company’s mission is to improve patient health by developing innovative medical technologies and treatments.
Boston Scientific Medical Devices
1 – Solyx™
Solyx™ is a medical device that is used for the treatment of stress urinary incontinence (SUI) in women. SUI is a condition where a person experiences involuntary leakage of urine during physical activities such as coughing, sneezing, laughing, or exercising. It is caused by the weakening of the pelvic floor muscles that support the bladder and urethra.
The Solyx™ device is designed to treat SUI by providing support to the urethra and bladder neck. It is a minimally invasive procedure that can be performed in an outpatient setting under local anesthesia. The device is made of a soft, flexible material that is implanted in the body through a small incision in the vaginal wall.
Once implanted, the Solyx™ device provides support to the urethra and bladder neck, reducing the likelihood of urine leakage during physical activities. The device is designed to remain in the body permanently, and most patients experience significant improvement in their symptoms within a few weeks of the procedure.
2 – Accurate neo2
The Acurate neo2 is a next-generation transcatheter aortic valve replacement (TAVR) system used to treat patients with severe aortic stenosis. Aortic stenosis is a condition in which the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes narrowed and stiff, making it difficult for the heart to pump blood effectively.
The Acurate neo2 system is designed to replace the diseased aortic valve with a new valve without the need for open-heart surgery. The device is inserted through a small incision in the groin or chest and guided to the heart through a catheter. Once in place, the new valve is expanded and anchored in the old valve’s place, improving blood flow and reducing symptoms of aortic stenosis.
One of the key features of the Acurate neo2 is its adaptability to different patient anatomies. The device is available in multiple sizes and can be positioned precisely in the aortic valve to ensure optimal performance. It also features a unique sealing technology that helps to prevent leaks around the valve after implantation.
3 – Watchman
The Watchman device is an alternative to long-term anticoagulation therapy for patients with atrial fibrillation. Anticoagulation therapy involves taking blood-thinning medications that can have significant side effects and require regular monitoring. The use of the Watchman can reduce the risk of stroke and eliminate the need for long-term anticoagulation therapy in some patients.
The safety and efficacy of the Watchman have been extensively studied, and it has been shown to be as effective as anticoagulation therapy in reducing the risk of stroke. However, the device may not be suitable for all patients, and a consultation with a healthcare provider is necessary to determine if the device is appropriate for a particular patient’s situation.
4 – Watchman FLX
Watchman FLX is a medical device used to reduce the risk of stroke in patients with atrial fibrillation (AFib). AFib is a condition where the heart beats irregularly, which can cause blood clots to form in the heart. These blood clots can then travel to the brain and cause a stroke.
This device is implanted using minimally invasive techniques and typically requires an overnight hospital stay. After the procedure, patients will need to take blood thinning medication for a period of time to prevent blood clots from forming around the device.
Its an effective alternative to long-term blood thinning medication for patients with AFib who are at risk of stroke. It has been shown to significantly reduce the risk of stroke in clinical studies and is approved for use in many countries around the world.
